Table 3.
Emetogenic potential of commonly used cytotoxics (without prophylaxis)
| Substance | Emetogenic potential, % |
|---|---|
| Cisplatin > 50 mg/m2 | > 90 (12–48ha) |
| Cyclophosphamide > 1,500 mg/m2 | > 90 (12–48ha) |
| Methotrexate > 1,000 mg/m2 | 60–90 |
| Cyclophosphamide > 750 – < 1,500 mg/m2 | 60–90 |
| Doxorubicin > 60 mg/m2 | 60–90 |
| Cyclophosphamide < 750 mg/m2 | 30–60 |
| Epirubicin < 90 mg/m2 | 30–60 |
| Docetaxel, paclitaxel | 10–30 |
| 5-Fluorouracil < 1,000 mg/m2 | 10–30 |
Delayed nausea and vomiting.